30.08.2018 | Research Article
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety
Erschienen in: Frontiers of Medicine | Ausgabe 3/2019
Einloggen, um Zugang zu erhaltenAnzeige